年轻患者家族性与散发性1型糖尿病的比较
基于DPV registry 1995-2018年57,371例20岁前发病的1型糖尿病患者,比较家族性(6.6%)与散发性(93.4%)1型糖尿病的自然病程、治疗和结局;家族性糖尿病起病更年轻、起病时酮症酸中毒和HbA1c更低、自身免疫合并症更多,10年病程中胰岛素泵使用更多、严重低血糖率更低,但HbA1c和酮症酸中毒率相似。
要点
- 家族性1型糖尿病起病年龄更小、起病时酮症酸中毒更少、HbA1c更低。
- 家族性1型糖尿病自身免疫合并症患病率更高。
- 10年随访中家族性糖尿病严重低血糖率更低,但HbA1c和酮症酸中毒率与散发性相似。
核心结论
- 家族性1型糖尿病相比散发性1型糖尿病起病更早、自身免疫合并症更多、起病时代谢失代偿更轻,可能与家族中疾病意识更高有关,而长期病程相似。
- 这些发现可能对糖尿病预防试验结果从家族性1型糖尿病患者向散发性1型糖尿病患者的外推有启示。
研究设计与样本
- 基于人群的研究,比较20岁前发病的1型糖尿病患者中有一级亲属患1型糖尿病者(家族性)与无一级亲属患1型糖尿病者(散发性)。
- 患者来自糖尿病前瞻性随访登记(DPV)1995年至2018年。
- 共57,371例1型糖尿病患者,其中散发性53,606例(93.4%),家族性3,765例(6.6%)。
- 在诊断时及治疗前10年使用多变量回归和比例风险模型进行比较。
主要发现
- 家族性糖尿病相比散发性糖尿病起病年龄更小(中位数7.9 vs. 9.7岁,P < 0.001)。
- 家族性糖尿病起病时酮症酸中毒患病率更低(11.9% vs. 20.4%,P < 0.001),HbA1c更低(9.7% vs. 11.1%,P < 0.001)。
- 家族性糖尿病起病时相关自身免疫病患病率更高(16.7% vs. 13.6%,P < 0.001)。
- 10年中家族性糖尿病更常使用胰岛素泵(P < 0.001),严重低血糖率更低(12.97 vs. 14.44每100患者年,P < 0.001)。
- 10年中家族性与散发性糖尿病HbA1c水平相似(P ≥ 0.08),酮症酸中毒率相似(1.85 vs. 2.06每100患者年,P = 0.11)。
关键数值与推荐
- 家族性糖尿病起病时酮症酸中毒11.9%,散发性20.4%(P < 0.001)。
- 家族性糖尿病起病时HbA1c 9.7%,散发性11.1%(P < 0.001)。
- 家族性糖尿病起病时自身免疫病16.7%,散发性13.6%(P < 0.001)。
- 10年严重低血糖率家族性12.97每100患者年,散发性14.44每100患者年(P < 0.001)。
- 起病时无酮症酸中毒预测10年后更少严重低血糖(家族性HR 0.67,P < 0.001;散发性HR 0.91,P < 0.001)和更少酮症酸中毒(家族性HR 0.64,P = 0.007;散发性HR 0.66,P < 0.001)。
临床怎么用
- 对有1型糖尿病家族史的年轻患者应关注起病时自身免疫合并症的筛查。
- 家族性1型糖尿病起病时代谢失代偿较轻,但仍需长期血糖管理,10年HbA1c与散发性相似。
- 起病时无酮症酸中毒与长期严重低血糖和酮症酸中毒风险更低相关,提示早期识别的重要性。
局限性
- 研究为观察性登记分析,可能存在未测量混杂因素。
- 家族性糖尿病定义基于一级亲属,可能低估家族聚集性。
- 结果基于DPV登记人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate natural course, treatment, and outcomes in familial versus sporadic type 1 diabetes. RESEARCH DESIGN AND METHODS: In a population-based study, we compared patients with onset of type 1 diabetes before the age of 20 years who had a first-degree relative with type 1 diabetes (familial diabetes) with patients with type 1 diabetes who had no first-degree relative with type 1 diabetes (sporadic diabetes) at diagnosis and over the first 10 treatment years, using multivariable regression and proportional hazards models. Patients were identified from the Diabetes Prospective Follow-up Registry (DPV) between 1995 and 2018. RESULTS: Of 57,371 patients with type 1 diabetes, 53,606 (93.4%) had sporadic diabetes and 3,765 (6.6%) had familial diabetes. Familial diabetes, compared with sporadic diabetes, was associated with younger age (median 7.9 vs. 9.7 years, P < 0.001), lower prevalence of ketoacidosis (11.9% vs. 20.4%, P < 0.001), and lower HbA1c levels (9.7% vs. 11.1%, P < 0.001) at onset and higher prevalence of associated autoimmune disease (16.7% vs. 13.6%, P < 0.001). Over 10 years, patients with familial diabetes, in comparison with sporadic diabetes, more often used insulin pumps (P < 0.001) and had a lower rate of severe hypoglycemia (12.97 vs. 14.44 per 100 patient-years, P < 0.001) but similar HbA1c levels (P ≥ 0.08) and ketoacidosis rates (1.85 vs. 2.06 per 100 patient-years, P = 0.11). In familial and sporadic diabetes, absence of ketoacidosis at onset predicted fewer events of severe hypoglycemia (hazard ratio [HR] 0.67, P < 0.001, and 0.91, P < 0.001, respectively) and of ketoacidosis (HR 0.64, P = 0.007, and 0.66, P < 0.001, respectively) after 10 years. CONCLUSIONS: Familial type 1 diabetes, compared with sporadic type 1 diabetes, is characterized by earlier disease manifestation and higher autoimmune comorbidity as well as less metabolic decompensation at onset, likely related to higher disease awareness in affected families, while the course of disease is similar. These findings may have implications for the generalizability of results of diabetes prevention trials from patients with familial type 1 diabetes to patients with sporadic type 1 diabetes.
引用
- Karges B, Prinz N, Placzek K, et al. A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients. Diabetes Care. 2021. PMID: 33824143. doi:10.2337/dc20-1829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。